Medical Therapy for Heart Failure With Reduced Ejection Fraction
2018 · Journal of the American College of Cardiology · 1,230 citations
https://doi.org/10.1016/j.jacc.2018.04.070
A
Adam D. DeVore
Duke University(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
530
Papers
14.9K
Citations
54
h-index
210
i10-index
Adam D. DeVore is an academic researcher from Duke University. The author has contributed to research in topics: Heart Failure Treatment and Management & Cardiovascular Function and Risk Factors & Mechanical Circulatory Support Devices. The author has an h-index of 54, co-authored 451 publications.
ORCID: 0000-0002-4679-2221Papers by this author
worksTitration of Medical Therapy for Heart Failure With Reduced Ejection Fraction
2019 · Journal of the American College of Cardiology · 475 citations
https://doi.org/10.1016/j.jacc.2019.02.015
Reassessing Recipient Mortality Under the New Heart Allocation System
2020 · JACC Heart Failure · 109 citations
https://doi.org/10.1016/j.jchf.2020.03.010
Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction
2020 · JACC Heart Failure · 55 citations
https://doi.org/10.1016/j.jchf.2020.05.005
Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry
2021 · Journal of Cardiac Failure · 36 citations
https://doi.org/10.1016/j.cardfail.2021.08.023
A Hospital Level Analysis of 30-Day Readmission Performance for Heart Failure Patients and Long-Term Survival: Findings from Get With The Guidelines-Heart Failure
2018 · American Heart Journal · 15 citations
https://doi.org/10.1016/j.ahj.2017.11.018
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat